Clinical Trial Update: VA106483 and Alpha Blocker Interaction Study in Elderly Males [Phase 1]

View source ↗

Summary

A Phase 1 trial is completed to evaluate the interaction between VA106483 and an alpha blocker in elderly males with nocturia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• VA106483

Snippet

Sponsor: Vantia Ltd | Conditions: Nocturia | Phase 1 | Status: COMPLETED